Biomedical Entrepreneur-in-Residence Program
The Biomedical Entrepreneur-in-Residence Program, hosted by Technology Ventures and Partnerships, brings expert biomedical entrepreneurs to NYU Langone to provide one-on-one guidance and support to researchers and clinicians who are interested in commercializing biomedical inventions and discoveries.
Our first entrepreneur-in-residence is Colin J. Foster, MBA, who has extensive experience in bringing biomedical products to market. Mr. Foster consults with interested faculty on the development of biomedical ventures based on novel NYU technologies.
For more information or to schedule a meeting with Mr. Foster, please email firstname.lastname@example.org.
Colin J. Foster, MBA, has more than 30 years of experience as a public and private life science company chairperson, executive chairperson, board member, chief executive officer, and entrepreneur. He has leadership experience across the research, development, and commercial continuum in therapeutics, diagnostics, and medical devices, and has led multibillion-dollar, midsized, small, and startup life science companies in the United States, Canada, United Kingdom, Ireland, and Israel.
Mr. Foster began his career in pharmaceutical marketing and sales, ultimately becoming president and chief executive officer of Bayer Pharmaceuticals North America. He then co-founded Optherion Inc., a venture-backed biotechnology company, where he was a board member and chief executive officer. He later transacted Optherion in two worldwide deals.
He subsequently became executive chair of Ivenix Inc., a venture-backed medical device company; board member and chief executive officer of Bioblast Pharma Ltd., a publicly traded biotechnology company; and founder and chief executive officer of iSci Management LLC, a strategic advisory firm.
Mr. Foster has a BSc in zoology and microbiology from the University of Toronto and an MBA from the Ivey Business School at Western University.